These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 4013136

  • 1. A pasteurized antithrombin III concentrate for clinical use.
    Smith JK, Winkelman L, Evans DR, Haddon ME, Sims G.
    Vox Sang; 1985; 48(6):325-32. PubMed ID: 4013136
    [Abstract] [Full Text] [Related]

  • 2. Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.
    Wickerhauser M, Williams C, Mercer J.
    Vox Sang; 1979; 36(5):281-93. PubMed ID: 462917
    [Abstract] [Full Text] [Related]

  • 3. A single-step method for the isolation of antithrombin III.
    Wickerhauser M, Williams C.
    Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
    [Abstract] [Full Text] [Related]

  • 4. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
    Biescas H, Gensana M, Fernández J, Ristol P, Massot M, Watson E, Vericat F.
    Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
    [Abstract] [Full Text] [Related]

  • 5. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L, Haddon ME.
    Thromb Res; 1986 Jul 15; 43(2):219-27. PubMed ID: 3738862
    [Abstract] [Full Text] [Related]

  • 6. Virus safety of pasteurized antithrombin III concentrate.
    Roggendorf M, Delvos U, Nováková-Banet A.
    Thromb Haemost; 1991 Feb 12; 65(2):212. PubMed ID: 1647061
    [No Abstract] [Full Text] [Related]

  • 7. [Preparation and characterization of an antithrombin III concentrate].
    Dornheim G, Schön R.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Feb 12; 109(6):870-7. PubMed ID: 6187640
    [Abstract] [Full Text] [Related]

  • 8. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
    D'Souza S, Ananthakrishnan R.
    Aust J Exp Biol Med Sci; 1979 Jun 12; 57(3):245-50. PubMed ID: 316999
    [Abstract] [Full Text] [Related]

  • 9. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion.
    Brandt P.
    Thromb Res; 1979 Jun 12; 22(1-2):15-24. PubMed ID: 7292437
    [Abstract] [Full Text] [Related]

  • 10. Purification and properties of guinea pig antithrombin III.
    Heck L, Rosenberg R, Remold H.
    Prep Biochem; 1979 Jun 12; 9(4):359-77. PubMed ID: 504072
    [Abstract] [Full Text] [Related]

  • 11. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
    Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.
    Br J Haematol; 1987 Aug 12; 66(4):515-22. PubMed ID: 3663508
    [Abstract] [Full Text] [Related]

  • 12. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency.
    Harper PL, Park GR, Carrell RW.
    Transfus Med; 1996 Mar 12; 6(1):45-50. PubMed ID: 8696447
    [Abstract] [Full Text] [Related]

  • 13. Manufacturing process of anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance.
    Morrica A, Nardini C, Falbo A, Bailey AC, Bucci E.
    Biologicals; 2003 Sep 12; 31(3):165-73. PubMed ID: 12935804
    [Abstract] [Full Text] [Related]

  • 14. Purification and large-scale preparation of antithrombin III.
    Hoffman DL.
    Am J Med; 1989 Sep 11; 87(3B):23S-26S. PubMed ID: 2801726
    [Abstract] [Full Text] [Related]

  • 15. Large-scale production and properties of human plasma-derived activated Factor VII concentrate.
    Tomokiyo K, Yano H, Imamura M, Nakano Y, Nakagaki T, Ogata Y, Terano T, Miyamoto S, Funatsu A.
    Vox Sang; 2003 Jan 11; 84(1):54-64. PubMed ID: 12542734
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
    Chang WS, Harper PL.
    Thromb Haemost; 1997 Feb 11; 77(2):323-8. PubMed ID: 9157590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antithrombin III concentrates.
    Menache D.
    Hematol Oncol Clin North Am; 1992 Oct 11; 6(5):1115-20. PubMed ID: 1400075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.